 Connection
David Orlicky to Anti-Bacterial Agents
This is a "connection" page, showing publications David Orlicky has written about Anti-Bacterial Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.239 |
|
|
|
-
Kim JS, Kumar V, Liu L, Choi YJ, Senovaityte S, McCollister BD, Wlodarchak N, Orlicky DJ, Rice PJ, Dai S, Wempe MF, Vázquez-Torres A. DksA inhibitors against intracellular and persistent Salmonella are effective in acute models of infection. Sci Adv. 2026 Mar 20; 12(12):eaea6832.
Score: 0.113
-
Escobedo HD, Zawadzki N, Till JKA, Vazquez-Torres A, Wang G, Simberg D, Orlicky DJ, Johnson J, Guess MK, Nair DP, Schurr MJ. Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections. Nanomedicine. 2025 04; 65:102812.
Score: 0.105
-
Hazleton KZ, Martin CG, Orlicky DJ, Arnolds KL, Nusbacher NM, Moreno-Huizar N, Armstrong M, Reisdorph N, Lozupone CA. Dietary fat promotes antibiotic-induced Clostridioides difficile mortality in mice. NPJ Biofilms Microbiomes. 2022 04 01; 8(1):15.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|